Opioid addiction continues to take a devastating toll across the country, with more than 80,000 lives lost each year. And yet, one of the most effective treatments available, buprenorphine, still isn’t being used nearly as often as it should be.

Buprenorphine is a key part of medication-assisted treatment (MAT) and has been shown to reduce cravings, prevent relapse, and lower the risk of fatal overdose. In countries like France, where the medication was embraced early, overdose deaths dropped by nearly 80%. But here in the U.S., access remains limited, and outdated beliefs are still getting in the way.

Stigma Still Stands in the Way

One of the biggest barriers to buprenorphine adoption is stigma, both in the community and within parts of the recovery landscape. Some still falsely believe that using a medication like Suboxone (a combination of buprenorphine and naloxone) means a person isn’t truly sober.

This misunderstanding prevents people from seeking treatment or staying on their medication plan. In some sober housing environments or support groups, individuals on MAT are still excluded or treated as if they’re in active addiction. This stigma is not only outdated, it’s dangerous.

Infrastructure & Education Are Lagging

Even as regulatory hurdles have eased like the removal of special training requirements for prescribers buprenorphine prescribing remains low. Many primary care practices don’t have the support systems in place to manage addiction treatment, and providers fear legal or DEA scrutiny.

Meanwhile, fentanyl has made initiating buprenorphine trickier. In people who’ve used fentanyl, starting treatment too soon can cause precipitated withdrawal, a rapid and painful detox reaction. However, medical professionals are actively working on solutions, including protocols that begin with naloxone (Narcan) or supportive medications like ketamine to ease transitions.

What Needs to Change

The problem isn’t that buprenorphine doesn’t work, it’s that it isn’t reaching the people who need it. Only 1 in 5 individuals with opioid use disorder receives medication-assisted treatment. That means four out of five people may be missing out on a life-saving option.

To reverse this trend, we must:

• Normalize medication-assisted recovery in housing, court, and clinical settings
• Educate providers, patients, and communities about the science of addiction and recovery
• Make treatment pathways low-barrier, flexible, and patient-centered

SaVida Health: Fighting Stigma with Science and Compassion

At SaVida Health, we provide evidence-based addiction treatment that respects the reality of modern opioid recovery. Our teams understand the complexities of treating fentanyl use and are trained to initiate MAT with safety and care.

Whether you’re a patient, family member, provider, or case manager, know this: buprenorphine can save lives. But only if we create the space, clinically, legally, and culturally, for people to use it.

We offer:

• Same-day and next-day appointments
• Telehealth availability for qualifying patients
• Care coordination with housing, food access, job support, and more
• Partnerships with probation, reentry programs, and community health workers

Refer or Get Help Today

If you know someone struggling with opioid addiction or you’re working with clients who need treatment—SaVida Health can help.

Call our referral line: (413) 333-5602
Contact Jeff Stern, Outreach Director: (540) 216-2137
Visit: savidahealth.com

Change is possible. Treatment is real. Let’s make sure more people can access it.